vs

Side-by-side financial comparison of RH (RH) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

DENTSPLY SIRONA Inc. is the larger business by last-quarter revenue ($961.0M vs $883.8M, roughly 1.1× RH). RH runs the higher net margin — 4.1% vs -15.2%, a 19.3% gap on every dollar of revenue. On growth, RH posted the faster year-over-year revenue change (8.9% vs 6.2%). RH produced more free cash flow last quarter ($83.0M vs $60.0M). Over the past eight quarters, RH's revenue compounded faster (9.4% CAGR vs 0.4%).

RH is an upscale American home-furnishings company headquartered in Corte Madera, California. The company sells its merchandise through its retail stores, catalog, and online. As of August 2018, the company operated a total of 70 galleries, 18 full-line design galleries, and 3 baby-and-child galleries. The company also has 36 outlet stores in the United States and Canada.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

RH vs XRAY — Head-to-Head

Bigger by revenue
XRAY
XRAY
1.1× larger
XRAY
$961.0M
$883.8M
RH
Growing faster (revenue YoY)
RH
RH
+2.7% gap
RH
8.9%
6.2%
XRAY
Higher net margin
RH
RH
19.3% more per $
RH
4.1%
-15.2%
XRAY
More free cash flow
RH
RH
$23.0M more FCF
RH
$83.0M
$60.0M
XRAY
Faster 2-yr revenue CAGR
RH
RH
Annualised
RH
9.4%
0.4%
XRAY

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
RH
RH
XRAY
XRAY
Revenue
$883.8M
$961.0M
Net Profit
$36.3M
$-146.0M
Gross Margin
44.1%
46.1%
Operating Margin
12.0%
-14.5%
Net Margin
4.1%
-15.2%
Revenue YoY
8.9%
6.2%
Net Profit YoY
9.3%
66.0%
EPS (diluted)
$1.83
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RH
RH
XRAY
XRAY
Q4 25
$883.8M
$961.0M
Q3 25
$899.2M
$904.0M
Q2 25
$814.0M
$936.0M
Q1 25
$812.4M
$879.0M
Q4 24
$811.7M
$905.0M
Q3 24
$829.7M
$951.0M
Q2 24
$727.0M
$984.0M
Q1 24
$738.3M
$953.0M
Net Profit
RH
RH
XRAY
XRAY
Q4 25
$36.3M
$-146.0M
Q3 25
$51.7M
$-427.0M
Q2 25
$8.0M
$-45.0M
Q1 25
$13.9M
$20.0M
Q4 24
$33.2M
$-430.0M
Q3 24
$29.0M
$-494.0M
Q2 24
$-3.6M
$-4.0M
Q1 24
$11.4M
$18.0M
Gross Margin
RH
RH
XRAY
XRAY
Q4 25
44.1%
46.1%
Q3 25
45.5%
48.8%
Q2 25
43.7%
52.4%
Q1 25
44.7%
53.0%
Q4 24
44.5%
49.3%
Q3 24
45.2%
52.1%
Q2 24
43.5%
51.9%
Q1 24
43.5%
53.1%
Operating Margin
RH
RH
XRAY
XRAY
Q4 25
12.0%
-14.5%
Q3 25
14.3%
-24.1%
Q2 25
6.9%
-13.7%
Q1 25
8.7%
7.2%
Q4 24
12.5%
-56.2%
Q3 24
11.6%
-48.6%
Q2 24
7.5%
5.1%
Q1 24
8.7%
4.4%
Net Margin
RH
RH
XRAY
XRAY
Q4 25
4.1%
-15.2%
Q3 25
5.8%
-47.2%
Q2 25
1.0%
-4.8%
Q1 25
1.7%
2.3%
Q4 24
4.1%
-47.5%
Q3 24
3.5%
-51.9%
Q2 24
-0.5%
-0.4%
Q1 24
1.5%
1.9%
EPS (diluted)
RH
RH
XRAY
XRAY
Q4 25
$1.83
$-0.74
Q3 25
$2.62
$-2.14
Q2 25
$0.40
$-0.22
Q1 25
$0.71
$0.10
Q4 24
$1.66
$-2.09
Q3 24
$1.45
$-2.46
Q2 24
$-0.20
$-0.02
Q1 24
$0.91
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RH
RH
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$43.1M
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$3.3M
$1.3B
Total Assets
$4.8B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RH
RH
XRAY
XRAY
Q4 25
$43.1M
$326.0M
Q3 25
$34.6M
$363.0M
Q2 25
$46.1M
$359.0M
Q1 25
$30.4M
$398.0M
Q4 24
$87.0M
$272.0M
Q3 24
$78.3M
$296.0M
Q2 24
$101.8M
$279.0M
Q1 24
$123.7M
$291.0M
Total Debt
RH
RH
XRAY
XRAY
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
RH
RH
XRAY
XRAY
Q4 25
$3.3M
$1.3B
Q3 25
$-40.9M
$1.5B
Q2 25
$-110.8M
$2.0B
Q1 25
$-163.6M
$2.0B
Q4 24
$-183.0M
$1.9B
Q3 24
$-234.7M
$2.5B
Q2 24
$-289.9M
$3.1B
Q1 24
$-297.4M
$3.3B
Total Assets
RH
RH
XRAY
XRAY
Q4 25
$4.8B
$5.4B
Q3 25
$4.7B
$5.7B
Q2 25
$4.7B
$6.1B
Q1 25
$4.6B
$6.0B
Q4 24
$4.5B
$5.8B
Q3 24
$4.4B
$6.6B
Q2 24
$4.2B
$6.9B
Q1 24
$4.1B
$7.1B
Debt / Equity
RH
RH
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RH
RH
XRAY
XRAY
Operating Cash FlowLast quarter
$131.9M
$101.0M
Free Cash FlowOCF − Capex
$83.0M
$60.0M
FCF MarginFCF / Revenue
9.4%
6.2%
Capex IntensityCapex / Revenue
5.5%
4.3%
Cash ConversionOCF / Net Profit
3.64×
TTM Free Cash FlowTrailing 4 quarters
$128.1M
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RH
RH
XRAY
XRAY
Q4 25
$131.9M
$101.0M
Q3 25
$137.7M
$79.0M
Q2 25
$86.6M
$48.0M
Q1 25
$-18.8M
$7.0M
Q4 24
$-31.4M
$87.0M
Q3 24
$11.2M
$141.0M
Q2 24
$56.1M
$208.0M
Q1 24
$-114.0M
$25.0M
Free Cash Flow
RH
RH
XRAY
XRAY
Q4 25
$83.0M
$60.0M
Q3 25
$80.7M
$40.0M
Q2 25
$34.1M
$16.0M
Q1 25
$-69.7M
$-12.0M
Q4 24
$-96.0M
$36.0M
Q3 24
$-37.9M
$98.0M
Q2 24
$-10.1M
$156.0M
Q1 24
$-251.5M
$-9.0M
FCF Margin
RH
RH
XRAY
XRAY
Q4 25
9.4%
6.2%
Q3 25
9.0%
4.4%
Q2 25
4.2%
1.7%
Q1 25
-8.6%
-1.4%
Q4 24
-11.8%
4.0%
Q3 24
-4.6%
10.3%
Q2 24
-1.4%
15.9%
Q1 24
-34.1%
-0.9%
Capex Intensity
RH
RH
XRAY
XRAY
Q4 25
5.5%
4.3%
Q3 25
6.3%
4.3%
Q2 25
6.5%
3.4%
Q1 25
6.3%
2.2%
Q4 24
8.0%
5.6%
Q3 24
5.9%
4.5%
Q2 24
9.1%
5.3%
Q1 24
18.6%
3.6%
Cash Conversion
RH
RH
XRAY
XRAY
Q4 25
3.64×
Q3 25
2.66×
Q2 25
10.78×
Q1 25
-1.35×
0.35×
Q4 24
-0.95×
Q3 24
0.39×
Q2 24
Q1 24
-10.01×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RH
RH

RH Segment$835.8M95%
Waterworks Segment$48.0M5%
Gift Card And Merchandise Credit$4.5M1%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons